ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024
ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024
ElectroCore的GammaCore療法將在2026年3月17日之前的兩年內繼續在英國國家衛生服務供應鏈目錄中列出。上市於2019年6月4日開始，計劃於2024年3月18日終止
ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024
ElectroCore的GammaCore療法將在2026年3月17日之前的兩年內繼續在英國國家衛生服務供應鏈目錄中列出。上市於2019年6月4日開始，計劃於2024年3月18日終止
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。